Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer
NCT05438927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-03-31
Summary
The purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition and supportive care for participants living with pancreatic cancer who are receiving chemotherapy.
Conditions
Interventions
- BEHAVIORAL
-
Fitbit Data Collection
Participants will log food intake while sharing their data with a dietician in real time for 12 weeks
- BEHAVIORAL
-
Nutrition Counseling
Participants will receive individually tailored, biweekly nutrition counseling from a dietician via telehealth
- BEHAVIORAL
-
Fact G Survey
Participants will take a survey at baseline and weeks 4,8,12 \& 16. The questionnaire includes questions about participant's physical, social, emotional and functional well being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher total score indicates better quality of life.
- BEHAVIORAL
-
General Anxiety Disorder (GAD)-7
Participants will take a survey at baseline and weeks 4,8,12 \& 16. The questionnaire measures participants anxiety with a scale of 0=not at all, 3=Nearly everyday.
- BEHAVIORAL
-
Patient Health Questionnaire (PHQ)-9
Participants will take a survey at baseline and weeks 4,8,12 \& 16. The questionnaire measures participants depression with a scale of 0=not at all, 3=Nearly everyday.
Sponsors & Collaborators
-
Canopy Cancer Collective
collaborator UNKNOWN -
H. Lee Moffitt Cancer Center and Research Institute
lead OTHER
Principal Investigators
-
Amir Alishahi Tabriz, MD, PhD · Moffitt Cancer Center
-
Pamela Hodul, MD · Moffitt Cancer Center
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-15
- Primary Completion
- 2024-10-16
- Completion
- 2025-09-30
Countries
- United States
Study Locations
More Related Trials
-
Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center
NCT06712797 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer
NCT03187951 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
NCT00805688 ·Status: COMPLETED
-
Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer
NCT05836870 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
NCT05356117 ·Status: RECRUITING ·Phase: NA
-
Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT00912717 ·Status: RECRUITING
-
Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer
NCT00902733 ·Status: COMPLETED ·Phase: NA
-
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study
NCT04837118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fatigue and Pancreas and Bile Duct Cancer Study
NCT00902759 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer
NCT00438256 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
NCT05687188 ·Status: RECRUITING
-
A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer
NCT03902600 ·Status: ACTIVE_NOT_RECRUITING
-
Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX
NCT03798769 ·Status: COMPLETED ·Phase: NA
-
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer
NCT05692323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
NCT05262855 ·Status: COMPLETED ·Phase: PHASE2
-
AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
NCT06320717 ·Status: RECRUITING
-
Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
NCT00536874 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer
NCT02745197 ·Status: WITHDRAWN ·Phase: PHASE2
-
CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas
NCT00540579 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Project Survival-Prospective Biomarker Discovery
NCT02781012 ·Status: UNKNOWN
-
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
NCT06595160 ·Status: RECRUITING
-
Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)
NCT06149546 ·Status: RECRUITING ·Phase: NA
-
PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma
NCT07047807 ·Status: RECRUITING ·Phase: NA
-
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
NCT05325281 ·Status: TERMINATED ·Phase: PHASE1
-
Supportive Care Intervention-Pancreas
NCT01885884 ·Status: COMPLETED ·Phase: NA